A 60-year-old man was referred for endoscopic ablation therapy of long-segment Barrett's esophagus with low-grade dysplasia. It is our practice to perform preablation therapy mapping, with EMR of areas of concern, before ablation therapy. On this examination, we found a long segment of Barrett's esophagus that was Prague class C5M6 (Fig. 1A) . No concerning areas were seen on high-definition white-light endoscopy (HDWLE) or narrow-band imaging (NBI) (Fig. 1B) . It is our practice to perform volumetric laser endomicroscopy (VLE) for all preablation mapping examinations to determine whether there are any areas of concern for neoplasia.
The VLE technique is a second-generation optical coherence tomography technology that uses infrared light to produce real-time high-resolution cross-sectional imaging of tissue. It has been cleared by the U.S. Food and Drug Administration for use in the GI tract and is currently marketed to aid in dysplasia detection in Barrett's esophagus. VLE can scan a 6-cm length of the esophagus in approximately 90 seconds, providing high-resolution wide-field microstructure cross-sectional imaging. Ex-vivo scoring systems have been developed to look at VLE features of dysplasia (Video 1, available online at www. VideoGIE.org).
The VLE was performed by use of a 20-mm balloon (Video 1). Two areas were identified that were of concern for neoplasia. Both were marked with laser marking (Figs. 1C and D) . The first area had partial effacement of layers and atypical glands (Fig. 1E) , whereas the second area had atypical glands and a dark surface intensity (Fig. 1F) . Given the concerning features, EMR was performed. The results of histologic analysis were consistent with high-grade dysplasia in both resection specimens (Fig. 1G) .
This video demonstrates that VLE can help aid in the detection of dysplasia in Barrett's esophagus even when HDWLE or NBI do not show any areas of concern. Studies are needed to show the incremental yield of dysplasia detection using VLE, in-vivo diagnostic accuracy, in-vivo classification for neoplasia associated with Barrett's esophagus, and cost utility. 
